JD Health International Inc. (HKG:6618)

Market Cap	120.47B -5.8%
Revenue (ttm)	81.73B +26.3%
Net Income	5.98B +29.2%
EPS	1.87 +27.3%
Shares Out	3.21B
PE Ratio	20.07
Forward PE	14.94
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,230,661
Open	37.20
Previous Close	37.52
Day's Range	37.20 - 38.06
52-Week Range	37.20 - 71.70
Beta	1.13
Analysts	Strong Buy
Price Target	73.30 (+93.4%)
Earnings Date	Aug 14, 2026

About JD Health International

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People’s Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical in...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2014
• Employees: 5,263
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6618

Financial Performance

In 2025, JD Health International's revenue was 73.44 billion, an increase of 26.28% compared to the previous year's 58.16 billion. Earnings were 5.38 billion, an increase of 29.16%.

Financial numbers in CNY

Analyst Summary

According to 18 analysts, the average rating for 6618 stock is "Strong Buy." The 12-month stock price target is $73.30, which is an increase of 93.40% from the latest price.

Price Target

$73.30

(93.40% upside)

Analyst Consensus: Strong Buy